2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Autor: Lyon, A. R., Lopez-Fernandez, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., Cutter, D. J., de Azambuja, E., de Boer, R. A., Dent, S. F., Farmakis, D., Gevaert, S. A., Gorog, D. A., Herrmann, J., Lenihan, D., Moslehi, J., Moura, B., Salinger, S. S., Stephens, R., Suter, T. M., Szmit, S., Tamargo, J., Thavendiranathan, P., Tocchetti, C. G., van der Meer, P., van der Pal, H. J. H., Lancellotti, P., Thuny, F., Abdelhamid, M., Aboyans, V., Aleman, B., Alexandre, J., Barac, A., Borger, M. A., Casado-Arroyo, R., Cautela, J., Celutkiene, J., Cikes, M., Cohen-Solal, A., Dhiman, K., Ederhy, S., Edvardsen, T., Fauchier, L., Fradley, M., Grapsa, J., Halvorsen, S., Heuser, M., Humbert, M., Jaarsma, T., Kahan, T., Konradi, A., Koskinas, K. C., Kotecha, D., Ky, B., Landmesser, U., Lewis, B. S., Linhart, A., Lip, G. Y. H., Lochen, M. -L., Malaczynska-Rajpold, K., Metra, M., Mindham, R., Moonen, M., Neilan, T. G., Nielsen, J. C., Petronio, A. -S., Prescott, E., Rakisheva, A., Salem, J. -E., Savarese, G., Sitges, M., Ten Berg, J., Touyz, R. M., Tycinska, A., Wilhelm, M., Zamorano, J. L.

Publikováno v: European Heart Journal-Cardiovascular Imaging, 23(10). Oxford University Press
European Heart Journal, 43(41), 4229-4361. Oxford University Press
Lyon, A R, López-Fernández, T, Couch, L S, Asteggiano, R, Aznar, M C, Bergler-Klein, J, Boriani, G, Cardinale, D, Cordoba, R, Cosyns, B, Cutter, D J, de Azambuja, E, de Boer, R A, Dent, S F, Farmakis, D, Gevaert, S A, Gorog, D A, Herrmann, J, Lenihan, D, Moslehi, J, Moura, B, Salinger, S S, Stephens, R, Suter, T M, Szmit, S, Tamargo, J, Thavendiranathan, P, Tocchetti, C G, van der Meer, P, van der Pal, H J H & ESC Scientific Document Group 2022, ' 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) : Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) ', European Heart Journal Cardiovascular Imaging, vol. 23, no. 10, pp. e333-e465 . https://doi.org/10.1093/ehjci/jeac106

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::723dbf7225f41b64ceec84b0f1e10400
https://doi.org/10.1093/eurheartj/ehac244

Transthyretin cardiac amyloidosis

Autor: Aldostefano Porcari, Marianna Fontana, Julian D Gillmore

Publikováno v: Cardiovascular Research. 118:3517-3535

Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) and mortality worldwide. Advances in non-invasive diagnosis, coupled with the development of effective treatments, have shifted ATTR-CA from a rare

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf52f8162db42dbb0735ec2043909a6
https://doi.org/10.1093/cvr/cvac119

A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation

Autor: Vincenzo Nuzzi, Aldostefano Porcari, Marta Gigli, Francesco Zaja, Franca Dore, Rossana Bussani, Gianfranco Sinagra, Marco Merlo

Publikováno v: European Heart Journal - Case Reports. 7

BackgroundCardiac involvement in amyloid light-chain (AL) amyloidosis usually represents a brick in the wall of a multi-system disease. The presence of cardiac deposition of free light chains (FLCs) is the main determinant of survival. Isolated cardi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a6183ffcaec851d024521cbafb6d29
https://doi.org/10.1093/ehjcr/ytad072

Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis]

Autor: Sinagra G., Emdin M., Merlo M., Vergaro G., Aimo A., Biagini E., Imazio M., Porcari A., Limongelli G., Cipriani A., Canepa M., Musumeci B., Cameli M., Crotti L., Di Bella G., Di Lenarda A., Cappelli F., Chimenti C., Obici L., Iacoviello M., Perlini S., Pieroni M., Metra M., Oliva F., Perrone Filardi P., Colivicchi F., Indolfi C.

The perspective on amyloidosis has changed deeply over the last 10 years following major advances in diagnosis and treatment options, especially in cardiac amyloidosis. This intrinsically heterogeneous disease exposes to the risk of fragmentation of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1299::53ddf1e9ce21307fc6face451b0ca653
https://hdl.handle.net/10281/404301

Differences between κ and λ light chain amyloidosis analyzed by a pathologic scoring system

Autor: Huijuan Wu, Vincenzo L’Imperio, Mattia Rossi, Meghan E Kapp, Paisit Paueksakon

ObjectivesAmyloid light chain (AL)-κ and AL-λ share common histopathologic changes; however, the potential difference in clinical manifestations, histologic findings, and clinical significance between the 2 subtypes remain unclear.MethodsIn a retro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::625cd24c337d41199dd4b829dbae03d4
https://hdl.handle.net/10281/406016